LIVINGSTON, N.J.--(BUSINESS WIRE)--Columbia Laboratories, Inc. (NASDAQ: CBRX - News) will hold a conference call on November 8, 2007 to discuss financial results of the three- and nine- months period ended September 30, 2007. Robert S. Mills, president and chief executive officer, and James A. Meer, senior vice president, chief financial officer and treasurer of Columbia Laboratories, will host the call. In addition, George W. Creasy, M.D., FACOG, vice president of clinical research, will review data on the effect of PROCHIVE® 8% (progesterone gel) in women with a short cervix in mid-pregnancy. The report on these data, entitled “Vaginal Progesterone Is Associated With a Decrease in Risk for Early Preterm Birth and Improved Neonatal Outcome in Women with a Short Cervix,” was published in the October issue of Ultrasound in Obstetrics & Gynecology (also known as The White Journal), the official publication of the International Society of Ultrasound in Obstetrics and Gynecology, and is available at:
